+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Zomig"

From
Analyzing the Global CNS Market 2018 - Product Thumbnail Image

Analyzing the Global CNS Market 2018

  • Report
  • April 2018
  • Global
From
  • 3 Results (Page 1 of 1)
Loading Indicator

Zomig is a brand of medication used to treat migraine headaches. It belongs to a class of drugs known as triptans, which are used to treat moderate to severe migraine pain. Zomig works by narrowing blood vessels around the brain, reducing inflammation and relieving pain. It is available in both oral and nasal spray forms. Zomig is one of the most commonly prescribed medications for migraine headaches, and is part of the larger Central Nervous System (CNS) drug market. CNS drugs are used to treat a variety of neurological conditions, including depression, anxiety, and epilepsy. The CNS drug market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the Zomig market include GlaxoSmithKline, Merck, Pfizer, and Novartis. Other companies, such as Teva Pharmaceuticals and Mylan, also produce generic versions of Zomig. Show Less Read more